首页> 外国专利> SCIENTIFICALLY MODULATED AND REPROGRAMMED TREATMENT (SMART) FAS/FASL VIRUS TECHNOLOGY INTENDED TO NEUTRALIZE T-HELPER CELLS INFECTED WITH THE HUMAN IMMUNODEFICIENCY VIRUS

SCIENTIFICALLY MODULATED AND REPROGRAMMED TREATMENT (SMART) FAS/FASL VIRUS TECHNOLOGY INTENDED TO NEUTRALIZE T-HELPER CELLS INFECTED WITH THE HUMAN IMMUNODEFICIENCY VIRUS

机译:科学调节和重新编程的治疗(SMART)FAS / FASL病毒技术,旨在使感染人类免疫缺陷病毒的T形细胞中和

摘要

Scientifically Modulated And Reprogrammed Treatment (SMART) Virus Fas/FasL technology is intended to terminate T-Helper cells infected with the Human Immunodeficiency Virus. The SMART-Fas/FasL Virus carrying Fas and FasL cell-surface receptors is capable of engaging a T-Helper cell infected by HIV that is expressing one or more FasL cell-surface receptors. When a T-Helper cell infected with HIV encounters a SMART-Fas/FasL Virus, the infected T-Helper cell's FasL cell-surface receptor will engage the SMART-Fas/FasL Virus's Fas receptor, then the SMART-Fas/FasL Virus's FasL will engage the infected T-Helper cell's Fas receptor, which will initiate apoptosis in the infected T-Helper cell. Given the HIV infected T-Helper cell will be triggered to die, HIV's safe haven inside the T-Helper cell will be eliminated and the threat of Acquired Immunodeficiency Syndrome caused by HIV is averted.
机译:科学调制和重新编程处理(SMART)病毒Fas / FasL技术旨在终止感染了人类免疫缺陷病毒的T-辅助细胞。携带Fas和FasL细胞表面受体的SMART-Fas / FasL病毒能够与表达一种或多种FasL细胞表面受体的HIV感染的T辅助细胞结合。当感染了HIV的T辅助细胞遇到SMART-Fas / FasL病毒时,被感染的T-辅助细胞的FasL细胞表面受体将与SMART-Fas / FasL病毒的Fas受体结合,然后与SMART-Fas / FasL病毒的FasL结合。会与受感染的T辅助细胞的Fas受体结合,从而启动受感染T辅助细胞的凋亡。如果感染了HIV的T-Helper细胞死亡,将消除HIV在T-Helper细胞内的避风港,避免由HIV引起的后天免疫机能丧失综合症的威胁。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号